|
1
|
Lohse N, Hansen AB, Gerstoft J and Obel N:
Improved survival in HIV-infected persons: Consequences and
perspectives. J Antimicrob Chemother. 60:461–463. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Maartens G, Celum C and Lewin SR: HIV
infection: Epidemiology, pathogenesis, treatment, and prevention.
Lancet. 384:258–271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brown TT and Qaqish RB: Antiretroviral
therapy and the prevalence of osteopenia and osteoporosis: A
meta-analytic review. AIDS. 20:2165–2174. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Del C, arpio-Cano FE, Dela Cadena RA and
Sawaya BE: HIV and bone disease: A perspective of the role of
microRNAs in bone biology upon HIV infection. J Osteoporos.
2013:5714182013.PubMed/NCBI
|
|
5
|
McComsey GA, Tebas P, Shane E, Yin MT,
Overton ET, Huang JS, Aldrovandi GM, Cardoso SW, Santana JL and
Brown TT: Bone disease in HIV infection: A practical review and
recommendations for HIV care providers. Clin Infect Dis.
51:937–946. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tebas P, Powderly WG, Claxton S, Marin D,
Tantisiriwat W, Teitelbaum SL and Yarasheski KE: Accelerated bone
mineral loss in HIV-infected patients receiving potent
antiretroviral therapy. AIDS. 14:F63–F67. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kanis JA: Assessment of fracture risk and
its application to screening for postmenopausal osteoporosis:
Synopsis of a WHO report. WHO Study Group. Osteoporos Int.
4:368–381. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Endo I and Mastumoto T: Bone and stem
cells: Regulatory mechanism of mesenchymal stem cell
differentiation to osteoblasts. Clin Calcium. 24:555–564. 2014.(In
Japanese). PubMed/NCBI
|
|
9
|
Komori T: Regulation of bone development
and maintenance by Runx2. Front Biosci. 13:898–903. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tellmann G: The E-Method: A highly
accurate technique for gene-expression analysis. Nat Methods.
3:i–ii. 2006. View
Article : Google Scholar
|
|
11
|
Jaiswal N, Haynesworth SE, Caplan AI and
Bruder SP: Osteogenic differentiation of purified, culture-expanded
human mesenchymal stem cells in vitro. J Cell Biochem. 64:295–312.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pittenger MF, Mackay AM, Beck SC, Jaiswal
RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and
Marshak DR: Multilineage potential of adult human mesenchymal stem
cells. Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xiao ZS, Liu SG, Hinson TK and Quarles LD:
Characterization of the upstream mouse Cbfa1/Runx2 promoter. J Cell
Biochem. 82:647–659. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cotter EJ, Malizia AP, Chew N, Powderly WG
and Doran PP: HIV proteins regulate bone marker secretion and
transcription factor activity in cultured human osteoblasts with
consequent potential implications for osteoblast function and
development. AIDS Res Hum Retroviruses. 23:1521–1530. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bedimo R, Maalouf NM, Zhang S, Drechsler H
and Tebas P: Osteoporotic fracture risk associated with cumulative
exposure to tenofovir and other antiretroviral agents. AIDS.
26:825–831. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Friis-Møller N, Reiss P, Sabin CA, Weber
R, Monforte A, El-Sadr W, Thiébaut R, De Wit S, Kirk O, Fontas E,
et al; DAD Study Group, . Class of antiretroviral drugs and the
risk of myocardial infarction. N Engl J Med. 356:1723–1735. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Flint OP, Noor MA, Hruz PW, Hylemon PB,
Yarasheski K, Kotler DP, Parker RA and Bellamine A: The role of
protease inhibitors in the pathogenesis of HIV-associated
lipodystrophy: Cellular mechanisms and clinical implications.
Toxicol Pathol. 37:65–77. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Duvivier C, Kolta S, Assoumou L, Ghosn J,
Rozenberg S, Murphy RL, Katlama C and Costagliola D; ANRS 121
Hippocampe study group, . Greater decrease in bone mineral density
with protease inhibitor regimens compared with nonnucleoside
reverse transcriptase inhibitor regimens in HIV-1 infected naive
patients. AIDS. 23:817–824. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Amiel C, Ostertag A, Slama L, Baudoin C,
N'Guyen T, Lajeunie E, Neit-Ngeilh L, Rozenbaum W and De Vernejoul
MC: BMD is reduced in HIV-infected men irrespective of treatment. J
Bone Miner Res. 19:402–409. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kodama H, Amagai Y, Sudo H, Kasai S and
Yamamoto S: Establishment of a clonal osteogenic cell linefrom
newborn mouse calvaria. Jap J Oral Biol. 23:899–901. 1981.
View Article : Google Scholar
|
|
21
|
Jain RG and Lenhard JM: Select HIV
protease inhibitors alter bone and fat metabolism ex vivo. J Biol
Chem. 277:19247–19250. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Malizia AP, Cotter E, Chew N, Powderly WG
and Doran PP: HIV protease inhibitors selectively induce gene
expression alterations associated with reduced calcium deposition
in primary human osteoblasts. AIDS Res Hum Retroviruses.
23:243–250. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Santiago F, Oguma J, Brown AM and Laurence
J: Noncanonical Wnt signaling promotes osteoclast differentiation
and is facilitated by the human immunodeficiency virus protease
inhibitor ritonavir. Biochem Biophys Res Commun. 417:223–230. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang MW, Wei S, Faccio R, Takeshita S,
Tebas P, Powderly WG, Teitelbaum SL and Ross FP: The HIV protease
inhibitor ritonavir blocks osteoclastogenesis and function by
impairing RANKL-induced signaling. J Clin Invest. 114:206–213.
2004. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ltd AL: Norvir® Tablets Summary
of Product Characteristics. 2010.
|
|
26
|
Komori T, Yagi H, Nomura S, Yamaguchi A,
Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, et al:
Targeted disruption of Cbfa1 results in a complete lack of bone
formation owing to maturational arrest of osteoblasts. Cell.
89:755–764. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lin L, Shen Q, Leng H, Duan X, Fu X and Yu
C: Synergistic inhibition of endochondral bone formation by
silencing Hif1α and Runx2 in trauma-induced heterotopic
ossification. Mol Ther. 19:1426–1432. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sims NA and Martin TJ: Coupling the
activities of bone formation and resorption: A multitude of signals
within the basic multicellular unit. Bonekey Rep. 3:4812014.
View Article : Google Scholar : PubMed/NCBI
|
